FDA head discusses challenges, criticisms

03/4/2007 | Houston Chronicle (tiered subscription model)

FDA commissioner Dr. Andrew von Eschenbach has faced numerous criticisms ranging from political and pharmaceutical industry influence at the agency to accusations of containing dissent and threatening whistle-blowers. In an interview, he acknowledged the challenges facing the FDA and said the group is "a team few people fully appreciate."

View Full Article in:

Houston Chronicle (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
Boise, ID